HIGHLIGHTS
- who: Atypical Macular Edema and collaborators from the Rajajinagar, Bangalore, India have published the Article: Case Report Atypical Refractory Macular Edema: Are We Missing Something?, in the Journal: (JOURNAL)
- what: The authors report a diabetic patient with atypical macular edema, nonresponsive to conventional treatment, who was investigated and diagnosed to have an underlying life-threatening systemic pathology. Decreasing the blood immunoglobulin level is the primary goal with plasmapheresis, systemic corticosteroids, or systemic chemotherapy.[12] After administering ocular treatment with intravitreal anti-vascular endothelial growth factor and steroid injections, the affected eyes do not show much . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.